Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Goulart
Isabela M B
IM
State Reference Center for Sanitary Dermatology and Leprosy, Clinical Hospital, Faculty of Medicine, Federal University of Uberlândia, Minas Gerai, Brazil. imbgoulart@ufu.br
Reis
Ana Cláudia S
AC
De Rezende
Tatiana M N
TM
Borges
Aércio S
AS
Ferreira
Marcelo S
MS
Nishioka
Sérgio A
SA
D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D001938:Brazil; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index
D007917:Leprostatic Agents; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin